Access Resources
381 - 390 of 7616 Results
Title
Year
- Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease2023RESTRICTEDTitle: Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00374-wBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00374-wCitation Count: 7
-
RESTRICTEDTitle: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studiesJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 59End Page: 67.e6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019Citation Count: 1
-
RESTRICTEDTitle: Damaged mitochondria recruit the effector NEMO to activate NF-κB signalingJournal Name: Molecular CellPublisher: Elsevier BVVol: 83Issue #: 17Start Page: 3188End Page: 3204.e7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2023.08.005Best OA location URL: http://www.cell.com/article/S109727652300641X/pdfCitation Count: 5
-
RESTRICTEDTitle: Leucine-rich repeat kinase 2 at a glanceJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 136Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1242/jcs.259724Best OA location URL: https://journals.biologists.com/jcs/article-pdf/136/17/jcs259724/3144584/jcs259724.pdfCitation Count: 3
- No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment2023RESTRICTEDTitle: No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairmentJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 185Issue #:Start Page: 106243End Page: 106243Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106243Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106243Citation Count: 5
- Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity2023RESTRICTEDTitle: Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversityJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 9Start Page: 107525End Page: 107525Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2023.107525Best OA location URL: http://www.cell.com/article/S2589004223016024/pdfCitation Count: 2
- Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice Experiment2023RESTRICTEDTitle: Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice ExperimentJournal Name: Patient Preference and AdherencePublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 2263End Page: 2277Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ppa.s420051Best OA location URL: https://www.dovepress.com/getfile.php?fileID=92760Citation Count: 0
- Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features2023RESTRICTEDTitle: Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic featuresJournal Name: Physica MedicaPublisher: Elsevier BVVol: 113Issue #:Start Page: 102647End Page: 102647Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2023.102647Citation Count: 2
- Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease2023RESTRICTEDTitle: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 80Issue #: 9Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2807607/jamaneurology_erickson_2023_oi_230049_1689611082.26721.pdfCitation Count: 5
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 2